NAS10028,142+0.54%S&P7,563+0.29%GOLD$3,929−1.02%BTC$77,513+1.09%VIX20.95−0.95%latest tape · as of 20:14 UTC · 3 Nov
The Screen · Financials · Banks - Diversified
Banco Bilbao Vizcaya Argentaria SA ADR
BBVA · the NYSE · USD · Market cap $134.5B · 123,193 employees
Banco Bilbao Vizcaya Argentaria, S.A., together with its subsidiaries, provides various financial services in Spain, Mexico, Turkey, South America, Europe, the United States, and Asia.
FAIL · Does not pass the screen
23.94 USD
Price as of 2 Nov 2026Daily close, not a live quote
Screened 2026-11-02 · the tape above runs as of 20:14 UTC · 3 Nov · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price23.94 USD at the 2 Nov 2026 close
Our value readUndervalued vs our fair value, as of 2 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 110.33, read 2026-11-02
Ethical does not pass the values gate
Price23.94 USD
Fair value30.00
Ethical score30.0/100
Value readUndervaluedas of 2 Nov 2026
Our investment reviews on this name
2026-10-02Read Markdown28.87-17.1% to today ✓Accumulation gives way to Markdown
2026-08-29Read Accumulation28.63-16.4% to today Markup gives way to Accumulation after a 23% rise in 8 weeks
2026-07-02Read Markup23.34+2.6% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Banco Bilbao Vizcaya Argentaria SAADR holds its Markdown at $23.94. The statistical read favours the sellers, held for 56 days.
As held on the ledger · 2026-11-02
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 56 days
Price at the screen
$23.94
Valuation
11.16 trailing · 8.95 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.90
The Workings
Five Screens, Shown in Full
Does not pass. Excluded industry: Banks - Diversified
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Excluded industry: Banks - Diversified
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Banco Bilbao Vizcaya Argentaria does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-02. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BBVA's ethical verdict changes
Today BBVA does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 2 Nov 2026: it trades at roughly a 22% discount to our $30.00 fair value, narrow competitive moat, 20.20% revenue growth.
Fair value range in USD, drawn from the 2026-11-02 screen. The gold marker is the market price at the same screen. A 20.2% discount to the base estimate.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Spain and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BBVA trades on the NYSE (the company is based in Spain). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-03Markdown$23.44-9.7%Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23.
2026-10-27Markdown$25.95+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23.
2026-10-20Markdown$25.95-0.7%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23.
2026-10-13Markdown$26.12-9.5%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23.
2026-10-02Markdown · changed$28.87+0.8%Entry 13
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23.
2026-07-30Markup$25.95+0.0%Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-28Markup$25.95+0.0%Entry 10
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-27Markup$25.95+0.0%Entry 9
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-26Markup$25.95+0.0%Entry 8
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 54%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (3 analysts) rates it hold, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
